Quantitative imaging of lymphatic function with liposomal indocyanine green

Cancer Research

Volumn 70, Issue 18, 2010, Pages 7053-7062

  Proulx, Steven T ^a   Luciani, Paola ^a   Derzsi, Stefanie ^a   Rinderknecht, Matthias ^a   Mumprecht, Viviane ^a   Leroux, Jean Christophe ^a   Detmar, Michael ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; LIPOSOME; VASCULOTROPIN C; COLORING AGENT; VASCULAR ENDOTHELIAL GROWTH FACTOR C, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CAPILLARY; CONTROLLED STUDY; DRUG FORMULATION; IMAGING; LYMPH FLOW; LYMPH NODE; LYMPH VESSEL; LYMPHATIC SYSTEM; LYMPHEDEMA; LYMPHOMA; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR VOLUME; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DIAGNOSTIC USE; EXPERIMENTAL MELANOMA; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; VASCULARIZATION;

ANIMALS; COLORING AGENTS; INDOCYANINE GREEN; INJECTIONS, INTRADERMAL; LIPOSOMES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 77956925182     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0271     Document Type: Article

References (51)

1. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008;3:367-97.
2. Jurisic G, Detmar M. Lymphatic endothelium in health and disease. Cell Tissue Res 2009;335:97-108.
3. Mattila MM-T, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, Härkönen PL. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 2002;98:946-51.
4. Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis. J Cell Mol Med 2009;13:1405-16.
5. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8.
6. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005; 201:1089-99.
7. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007;109:1010-7.
8. Van den Eynden GG, Vandenberghe MK, Van Dam PJ, et al. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res 2007;13:5391-7.
9. Barrett T, Choyke P, Kobayashi H. Imaging of the lymphatic system: new horizons. Contrast Media Mol Imaging 2006;1:230-45.
10. Kobayashi H, Kawamoto S, Bernardo M, Brechbiel M, Knopp M, Choyke P. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 2006;111:343-51.
11. Kobayashi H, Kawamoto S, Star R, Waldmann T, Tagaya Y, Brechbiel M. Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res 2003;63:271-6.
12. Wunderbaldinger P, Josephson L, Bremer C, Moore A, Weissleder R. Detection of lymph node metastases by contrast-enhanced MRI in an experimental model. Magn Reson Med 2002;47:292-7.
13. Misselwitz B. MR contrast agents in lymph node imaging. Eur J Radiol 2006;58:375-82.
14. Herborn C, Lauenstein T, Vogt F, Lauffer RB, Debatin JF, Ruehm SG. Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. Am J Roentgenol 2002;179:1567-72.
15. Rasmussen JC, Tan I-C, Marshall MV, Fife CE, Sevick-Muraca EM. Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 2009;20:74-82.
16. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003;7:626-34.
17. Rao J, Dragulescuandrasi A, Yao H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007;18:17-25.
18. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960;39:592-600.
19. Saxena V, Sadoqi M, Shao J. Degradation kinetics of indocyanine green in aqueous solution. J Pharm Sci 2003;92:2090-7.
20. Sharma R, Wang W, Rasmussen JC, et al. Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol 2007;292: H3109-18.
21. Unno N, Nishiyama M, Suzuki M, et al. Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Vasc Endovasc Surg 2008;36:230-6.
22. Sharma R, Wendt JA, Rasmussen JC, Adams KE, Marshall MV, Sevick-Muraca EM. New horizons for imaging lymphatic function. Ann N Y Acad Sci 2008;1131:13-36.
23. Saxena V, Sadoqi M, Shao J. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Int J Pharm 2004;278:293-301.
24. Devoisselle J-M, Soulie-Begu S, Maillols H, Desmettre T, Mordon SR. Fluorescence properties of indocyanin green. II. In-vitro study related to in-vivo behavior. Proc SPIE 1997;2980:293-302.
25. Mordon S, Devoisselle JM, Soulie-Begu S, Desmettre T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res 1998;55:146-52.
26. Moody ED, Viskari PJ, Colyer CL. Non-covalent labeling of human serum albumin with indocyanine green: a study by capillary electrophoresis with diode laser-induced fluorescence detection. J Chromatogr B Biomed Sci Appl 1999;729:55-64.
27. Ohnishi S, Lomnes SJ, Laurence RG, Gogbashian A, Mariani G, Frangioni JV. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 2005;4:172-81.
28. Sadoqi M, Kumar S, Lau-Cam C, Saxena V. Biocompatible nanoparticulate systems for tumor diagnosis and therapy. In: Kumar CSSR, editor. Nanotechnologies for life sciences. Weinheim: Wiley-VCH Verlag GmbH & Co.; 2006. p. 304-48.
29. Bahner M, Haag R, Heek T, Licha K, Schirner M, Wyszogrodzka M, inventors; Mivenion GmbH, assignee. New polyether polyol dendron conjugate comprises a polyether polyol dendron moiety, and at least one effector molecule, e.g. fluorescent dyes, useful for treating or diagnosing a disease state or condition, e.g. tumors and atherosclerosis. United States patent WO2009112488-A2. 2009 Sept 16.
30. Devoisselle J-M, Soulie-Begu S, Mordon SR, Desmettre T, Maillols H. Fluorescence properties of indocyanin green. I. In-vitro study with micelles and liposomes. Proc SPIE 1997;2980:453-60.
31. Kirchherr A-K, Briel A, Mäder K. Stabilization of indocyanine green by encapsulation within micellar systems. Mol Pharm 2009;6:480-91.
32. Lasic DD. Novel applications of liposomes. Trends Biotechnol 1998; 16:307-21.
33. Hope MJ, Bally MB, Webb G, Cullis PR. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta 1985;812:55-65.
34. Pfohl T, Riegler H. Critical wetting of a liquid/vapor interface by octane. Phys Rev Lett 1999;82:783.
35. Karlsen TV, Karkkainen MJ, Alitalo K, Wiig H. Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema. J Physiol 2006;574:583-96.
36. Li J, Wang E, Rinaldo F, Datta K. Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway. Oncogene 2005;24:5510-20.
37. Tuomela J, Valta M, Seppanen J, Tarkkonen K, Vaananen HK, Harkonen P. Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors. BMC Cancer 2009;9:362.
38. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007;170:774-86.
39. Vandenbroeck W, Derore A, Simoens P. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 2006;312:12-9.
40. Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001;61:1786-90.
41. Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1991;1070: 187-92.
42. Harrell MI, Iritani BM, Ruddell A. Lymph node mapping in the mouse. J Immunol Methods 2008;332:170-4.
43. Weissleder R, Thrall JH. The lymphatic system: diagnostic imaging studies. Radiology 1989;172:315-7.
44. Oussoren C, Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 2001;50:143-56.
45. Phillips WT, Goins BA, Medina LA. Targeting of liposomes to lymph nodes. In: Gregoriadis G, editor. Liposome technology. 3rd ed. New York (NY): Informa Healthcare; 2007. p. 231-52.
46. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Non-invasive imaging of quantum dots in mice. Bioconjug Chem 2004;15: 79-86.
47. Hoshida T, Isaka N, Hagendoorn J, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006;66:8065-75.
48. Hayashi K, Jiang P, Yamauchi K, et al. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res 2007;67:8223-8.
49. Goyal A, Douglas-Jones AG, Newcombe RG, Mansel RE. Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer. Breast J 2005;11:188-94.
50. Wong SL, Edwards MJ, Chao C, Simpson D, McMasters KM. The effect of lymphatic tumor burden on sentinel lymph node biopsy results. Breast J 2002;8:192-8.
51. Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV. Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 2006;13: 1671-81.